AU2001269584A1 - Human cervical cancer 2 protooncogene and protein encoded therein - Google Patents

Human cervical cancer 2 protooncogene and protein encoded therein

Info

Publication number
AU2001269584A1
AU2001269584A1 AU2001269584A AU6958401A AU2001269584A1 AU 2001269584 A1 AU2001269584 A1 AU 2001269584A1 AU 2001269584 A AU2001269584 A AU 2001269584A AU 6958401 A AU6958401 A AU 6958401A AU 2001269584 A1 AU2001269584 A1 AU 2001269584A1
Authority
AU
Australia
Prior art keywords
protooncogene
cervical cancer
human cervical
protein encoded
cancers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269584A
Inventor
Jin Woo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001269584A1 publication Critical patent/AU2001269584A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A human cervical cancer 2 protooncogene having a base sequence of SEQ ID: 1 or a fragment thereof is overexpressed in various cancer tissues and can be used in diagnosing various cancers and an anti-sense gene complementary thereto can be used in treating cancers.
AU2001269584A 2000-11-28 2001-07-09 Human cervical cancer 2 protooncogene and protein encoded therein Abandoned AU2001269584A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2000-0071202A KR100426453B1 (en) 2000-11-28 2000-11-28 Human cervical cancer 2 protooncogene and protein encoded by same, expression vector containing same, and cell transformed by said vector
KR0071202 2000-11-28
PCT/KR2001/001172 WO2002044370A1 (en) 2000-11-28 2001-07-09 Human cervical cancer 2 protooncogene and protein encoded therein

Publications (1)

Publication Number Publication Date
AU2001269584A1 true AU2001269584A1 (en) 2002-06-11

Family

ID=36178350

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269584A Abandoned AU2001269584A1 (en) 2000-11-28 2001-07-09 Human cervical cancer 2 protooncogene and protein encoded therein

Country Status (11)

Country Link
US (1) US6905844B2 (en)
EP (1) EP1346039B1 (en)
JP (1) JP3730623B2 (en)
KR (1) KR100426453B1 (en)
CN (1) CN1246458C (en)
AT (1) ATE321858T1 (en)
AU (1) AU2001269584A1 (en)
CA (1) CA2430331A1 (en)
DE (1) DE60118382T2 (en)
ES (1) ES2261429T3 (en)
WO (1) WO2002044370A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426454B1 (en) * 2000-11-28 2004-04-13 김진우 Human protooncogene and protein encoded therein
KR100426452B1 (en) * 2001-01-02 2004-04-13 김진우 Transgenic mammal containing human protooncogene and kit for diagnosing breast, kidney, ovary or stomach cancer
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
KR100545064B1 (en) * 2003-05-26 2006-01-24 김현기 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
JP2009536313A (en) 2006-01-11 2009-10-08 レインダンス テクノロジーズ， インコーポレイテッド Microfluidic devices and methods for use in nanoreactor formation and control
US20080014589A1 (en) 2006-05-11 2008-01-17 Link Darren R Microfluidic devices and methods of use thereof
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US8503924B2 (en) * 2007-06-22 2013-08-06 Kenneth W. Dion Method and system for education compliance and competency management
KR100915609B1 (en) * 2007-10-25 2009-09-03 김현기 Human protooncogene and protein encoded therein
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
EP3736281A1 (en) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
EP2714970B1 (en) 2011-06-02 2017-04-19 Raindance Technologies, Inc. Enzyme quantification
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
EP2823303A4 (en) 2012-02-10 2015-09-30 Raindance Technologies Inc Molecular diagnostic screening assay
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
EP3194563B1 (en) 2014-09-17 2023-05-10 Hologic, Inc. Method of partial lysis and assay
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
JP2023515397A (en) * 2020-02-17 2023-04-13 スリーエム イノベイティブ プロパティズ カンパニー Loop-mediated isothermal amplification primers and their use for the detection of Vibrio parahaemolyticus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
EP0673252A4 (en) * 1992-12-14 1998-07-15 Start Technology Partnership Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies.
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
JP3524535B2 (en) * 1999-10-15 2004-05-10 キム、ジン・ウー Human cervical cancer 1 proto-oncogene and protein encoded thereby

Also Published As

Publication number Publication date
EP1346039A1 (en) 2003-09-24
DE60118382D1 (en) 2006-05-18
CA2430331A1 (en) 2002-06-06
KR100426453B1 (en) 2004-04-13
WO2002044370A1 (en) 2002-06-06
KR20020041550A (en) 2002-06-03
CN1246458C (en) 2006-03-22
EP1346039A4 (en) 2005-01-19
ATE321858T1 (en) 2006-04-15
DE60118382T2 (en) 2006-12-14
US6905844B2 (en) 2005-06-14
EP1346039B1 (en) 2006-03-29
ES2261429T3 (en) 2006-11-16
CN1476478A (en) 2004-02-18
US20040029199A1 (en) 2004-02-12
JP3730623B2 (en) 2006-01-05
JP2004514446A (en) 2004-05-20

Similar Documents

Publication Publication Date Title
AU2001269584A1 (en) Human cervical cancer 2 protooncogene and protein encoded therein
EP2258383A3 (en) Antigenic peptides derived from telomerase
DE69434447D1 (en) PLASMIDE FOR GENE THERAPY
NO990001D0 (en) Preparation and use of Radium-223 in the treatment of calcified tissue in connection with pain relief, in bone cancer and in the treatment of bone surface
WO1998055607A3 (en) Tumor targeted vector
NZ518696A (en) Use of epidermal growth factor receptor (EGFR) tyrosine kinease enzyme to treat invasive breast cancer
NZ541013A (en) A composition comprising a polypeptide comprising SEQ ID NO:577 for use in treating chlamydial infection
CA2353788A1 (en) Human cervical cancer 1 protooncogene and protein encoded therein
MY164077A (en) Compositions and uses of et743 for treating cancer
DE69920885D1 (en) C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)"
GB9824437D0 (en) Gene therapy
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2002221159A1 (en) Human protooncogene and protein encoded therein
HUP0201868A2 (en) Antisense therapy for hormone-regulated tumors
PT1417308E (en) Human protooncogene kg-20 and protein encoded therein
WO2003076563A3 (en) Human protooncogene and protein encoded therein
AU3556901A (en) Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
WO2003026494A3 (en) Galectins-1-and-4 in tumor development
WO1994028176A3 (en) Bc200 rna, probes therefor and use thereof
WO2002029104A8 (en) Tumor marker and methods of use
IL129368A0 (en) Immunogenic TLP composition
WO2005049818A3 (en) Genes encoding human deubiquitinating enzymes
WO2000058464A3 (en) Rab genes and their uses
AU2769101A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
AU3796297A (en) Pituitary differentiation factor and methods of use thereof